Table 1.
Patient demographics, comorbidities, preoperative laboratory values, and surgical treatments for all patients and stratified by the presence or absence of underlying NASH
| All patients | NASH | Non-NASH | p | |
|---|---|---|---|---|
| (n=181) | (n=31) | (n=150) | ||
| Age (years) | 64 (56–71) | 63 (56–71) | 64 (56–71) | 0.58 |
| Female gender | 97 (53.6 %) | 16 (51.6 %) | 81 (54.0 %) | 0.80 |
| Caucasian ethnicitya | 172 (95.0 %) | 27 (87.1 %) | 145 (96.7 %) | 0.03 |
| Diabetes mellitus | 45 (24.9 %) | 12 (38.7 %) | 33 (22.0 %) | 0.05 |
| Hypertension | 77 (42.5 %) | 12 (38.7 %) | 65 (43.3 %) | 0.64 |
| Dyslipidemia | 44 (24.3 %) | 10 (32.3 %) | 34 (22.7 %) | 0.26 |
| Body mass index (kg/m2) | 26.3 (23.5–28.4) | 30.0 (28.2–31.8) | 26.0 (23.3–27.7) | <0.001 |
| Metabolic syndrome | 22 (12.2 %) | 7 (22.6 %) | 15 (10.0 %) | 0.05 |
| Albumin (mg/dL) | 4.2 (3.8–4.5) | 4.2 (3.7–4.6) | 4.2 (3.8–4.5) | 0.81 |
| Bilirubin (mg/dL) | 0.9 (0.5–1.3) | 0.6 (0.6–1.1) | 0.9 (0.5–1.3) | 0.31 |
| CA 19–9 (U/mL) | 74.0 (18.5–222.5) | 26.5 (8.5–198.0) | 77.5 (22.4–231.5) | 0.58 |
| Bilobar liver tumor involvement | 50 (27.6 %) | 10 (32.3 %) | 40 (26.7 %) | 0.53 |
| Extent of surgical resection | ||||
| Less than hemihepatectomy | 59 (32.6 %) | 12 (38.7 %) | 47 (31.3 %) | 0.50 |
| Hemihepatectomy | 72 (39.8 %) | 13 (41.9 %) | 59 (39.3 %) | |
| Extended hepatectomy | 50 (27.6 %) | 6 (19.4 %) | 44 (29.3 %) |
Discrete variable are reported with associated percentages, continuous variables are reported as median (25–75th percentile)
a
Non-Caucasian ethnicity includes black, Hispanic, and Asian-Pacific Islander